Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder

Published:2021-12-28 Issue: Volume: Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Kadouh Nour K.¹,Lang Stacy²,Shamoun Mark²,Scott Eric L.³,Singh Sharon A.²^ORCID,Smith Michael A.¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy University of Michigan College of Pharmacy Ann Arbor Michigan USA

2. Department of Pediatrics University of Michigan Medical School Ann Arbor Michigan USA

3. Departments of Pediatrics and Anesthesiology University of Michigan Medical School Ann Arbor Michigan USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29526

Reference16 articles.

1. Sickle cell disease

2. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain

3. Daily Assessment of Pain in Adults with Sickle Cell Disease

4. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

5. Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2022-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP